Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:711-714

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, T.
Right arrow Articles by Ogihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, T.
Right arrow Articles by Ogihara, T.

(Hypertension. 1995;25:711-714.)
© 1995 American Heart Association, Inc.


Articles

cGMP Upregulates Nitric Oxide Synthase Expression in Vascular Smooth Muscle Cells

Takuo Inoue; Keisuke Fukuo; Takeshi Nakahashi; Shigeki Hata; Shigeto Morimoto; Toshio Ogihara

From the Department of Geriatric Medicine, Osaka (Japan) University Medical School.

Correspondence to Keisuke Fukuo, MD, Department of Geriatric Medicine, Osaka University Medical School, Suita, Osaka 565, Japan.

Abstract 8-Bromo-guanosine 3':5'-cyclic monophosphate (8-Br-cGMP), an analogue of cyclic guanosine monophosphate (cGMP), induced a time- and dose-dependent enhancement of interleukin-1–induced nitric oxide production in vascular smooth muscle cells. Human atrial natriuretic polypeptide, which stimulates cGMP accumulation in vascular smooth muscle cells, also enhanced interleukin-1–induced nitric oxide release at a concentration of 100 nmol/L. In contrast, coincubation with 10 µmol/L methylene blue, an inhibitor of soluble guanylate cyclase, inhibited interleukin-1–induced nitric oxide release from vascular smooth muscle cells. Furthermore, coincubation with 8-Br-cGMP also enhanced the interleukin-1–induced increase in inducible nitric oxide synthase messenger RNA in vascular smooth muscle cells. However, the enhancement of nitric oxide production induced by 8-Br-cGMP was significantly prevented by coincubation with neutralizing antibody against tumor necrosis factor–{alpha}. Furthermore, 8-Br-cGMP enhanced the interleukin-1–induced increase in tumor necrosis factor–{alpha} messenger RNA level in vascular smooth muscle cells. These findings indicate that cGMP may upregulate inducible nitric oxide synthase gene expression through the stimulation of tumor necrosis factor–{alpha} production in vascular smooth muscle cells. Thus, there may be a positive feedback mechanism between nitric oxide and the cGMP system in vascular smooth muscle cells.


Key Words: nitric oxide • guanosine cyclic monophosphate • muscle, smooth, vascular • tumor necrosis factor • interleukin-1




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
B.-N. Wu, C.-W. Chen, S.-F. Liou, J.-L. Yeh, H.-H. Chung, and I.-J. Chen
Inhibition of Proinflammatory Tumor Necrosis Factor-{alpha}-Induced Inducible Nitric-Oxide Synthase by Xanthine-Based 7-[2-[4-(2-Chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in Rat Trachea: The Involvement of Soluble Guanylate Cyclase and Protein Kinase G
Mol. Pharmacol., September 1, 2006; 70(3): 977 - 985.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. B. Pilz and D. E. Casteel
Regulation of Gene Expression by Cyclic GMP
Circ. Res., November 28, 2003; 93(11): 1034 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-Y. Qian, A. Haruno, Y. Asada, T. Nishida, Y. Saito, T. Matsuda, and H. Ueno
Local Expression of C-Type Natriuretic Peptide Suppresses Inflammation, Eliminates Shear Stress-Induced Thrombosis, and Prevents Neointima Formation Through Enhanced Nitric Oxide Production in Rabbit Injured Carotid Arteries
Circ. Res., November 29, 2002; 91(11): 1063 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Perez-Sala, E. Cernuda-Morollon, M. Diaz-Cazorla, F. Rodriguez-Pascual, and S. Lamas
Posttranscriptional regulation of human iNOS by the NO/cGMP pathway
Am J Physiol Renal Physiol, March 1, 2001; 280(3): F466 - F473.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
I. A. Buhimschi, C. Yallampalli, C. S. Buhimschi, G. R. Saade, and R. E. Garfield
Distinct regulation of nitric oxide and cyclic guanosine monophosphate production by steroid hormones in the rat uterus
Mol. Hum. Reprod., May 1, 2000; 6(5): 404 - 414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. C. Brady, J. D. Crapo, and R. R. Mercer
Nitric oxide inhalation transiently elevates pulmonary levels of cGMP, iNOS mRNA, and TNF-alpha
Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L509 - L515.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Kiemer and A. M. Vollmar
Autocrine Regulation of Inducible Nitric-oxide Synthase in Macrophages by Atrial Natriuretic Peptide
J. Biol. Chem., May 29, 1998; 273(22): 13444 - 13451.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. K. Kiemer and A. M. Vollmar
Effects of Different Natriuretic Peptides on Nitric Oxide Synthesis in Macrophages
Endocrinology, October 1, 1997; 138(10): 4282 - 4290.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. C. LaPointe and J. R. Sitkins
Mechanisms of Interleukin-1ß Regulation of Nitric Oxide Synthase in Cardiac Myocytes
Hypertension, March 1, 1996; 27(3): 709 - 714.
[Abstract] [Full Text]